Cornerstone Therapeutics (CRTX)
|
5.55
+0.10 (+1.83%)
|
|
|
|
CRTX additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CRTX Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
H&Q Life Sciences Investors
Satuit Capital Micro Cap
iShares Russell 2000 Value Index
Principal SmallCap Growth R2
CREF Stock
TIAA-CREF Small-Cap Equity Instl
America First Quantitative Strategies A
Principal SmallCap Blend R2
Gerstein Fisher Multi-Factor Gr Eq Inst
iShares Russell Microcap Index
Satuit Capital Micro Cap
iShares Russell 2000 Value Index
Principal SmallCap Growth R2
CREF Stock
TIAA-CREF Small-Cap Equity Instl
America First Quantitative Strategies A
Principal SmallCap Blend R2
Gerstein Fisher Multi-Factor Gr Eq Inst
iShares Russell Microcap Index
•
Executives
Mr. Craig A. Collard
Chairman
Chief Exec. Officer Chief Exec. Officer of Cornerstone Biopharma Holdings Ltd and Pres of Cornerstone Biopharma Holdings Ltd
Mr. Kenneth R. Mcbean
Pres
Mr. Vincent T. Morgus
Chief Financial Officer
Exec. VP of Fin. and Treasurer
Mr. Andrew K.W. Powell Esq.
Exec. VP
Sec. and Gen. Counsel
Mr. Alan T. Roberts
VP of Scientific Affairs
Chairman
Chief Exec. Officer Chief Exec. Officer of Cornerstone Biopharma Holdings Ltd and Pres of Cornerstone Biopharma Holdings Ltd
Mr. Kenneth R. Mcbean
Pres
Mr. Vincent T. Morgus
Chief Financial Officer
Exec. VP of Fin. and Treasurer
Mr. Andrew K.W. Powell Esq.
Exec. VP
Sec. and Gen. Counsel
Mr. Alan T. Roberts
VP of Scientific Affairs
•
Employee Count
116
Special Offers
Competitors
CRTX earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
0.19
0.32
0.13
8/9/2012
0.11
-0.02
0.11
5/15/2012
0.05
0.10
0.17
